The rapid spread of a new coronavirus infection (COVID-19) requires innovative solutions, including tactics optimization in using genetically engineered and targeted drugs patients with immuno-inflammatory rheumatic diseases (RD). authors studied the characteristics complex therapy RD COVID-19 pandemic conditions, analyzed course who received combined basic synthetic anti-rheumatic were under f...